Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
CNTX holding history
Context Therapeutics Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CNTX overviewAll 13F holders of CNTXFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −402,653−100.0% | Sold out | Holders |
| Q3 2025 | 402,653 | $390.1K | <0.1% | −115,372−22.3% | Reduced | Holders |
| Q2 2025 | 518,025 | $339.4K | 0.1% | −142,564−21.6% | Reduced | Holders |
| Q1 2025 | 660,589 | $404.3K | 0.1% | −354,751−34.9% | Reduced | Holders |
| Q4 2024 | 1,015,340 | $1.07M | 0.2% | −305,813−23.1% | Reduced | Holders |
| Q3 2024 | 1,321,153 | $2.59M | 0.4% | −297,987−18.4% | Reduced | Holders |
| Q2 2024 | 1,619,140 | $3.25M | 0.5% | +1,290,323+392.4% | Added | Holders |
| Q1 2024 | 328,817 | $453.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 328,817 | $371.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 328,817 | $496.5K | 0.2% | +61,243+22.9% | Added | Holders |
| Q2 2023 | 267,574 | $428.1K | 0.2% | +267,574 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −883,654−100.0% | Sold out | Holders |
| Q4 2022 | 883,654 | $583.7K | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2022 | 883,654 | $981.0K | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2022 | 883,654 | $1.87M | 1.0% | +106,044+13.6% | Added | Holders |
| Q1 2022 | 777,610 | $1.69M | 0.7% | +777,610 | New | Holders |